VR Logo

Hikal Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1988

Chairman: Jai Hiremath

Managing Director: Jai Hiremath

Group: Kalyani

Listing: NSE: HIKAL, BSE: 524735

Headquarters: Mumbai, Maharashtra

Website: www.hikal.com

Key Facts

Market cap: R 1,486.39 Cr

Revenue (TTM): R 1,585.77 Cr

Earnings (TTM): R 93.30 Cr

Cash: R 31.74 Cr

Total Debt: R 660.92 Cr

Promoters' ownership: 68.77%

Liquidity: High

52 Week range: R 56.90 - 177.80

Face value: R2.00

Shares outstanding: 12,33,00,750

10 Years Aggregate:

  • CFO: 1,353.39 Cr
  • EBITDA: 1,891.98 Cr
  • Net Profit: 551.82 Cr

Stock Performance

Time Period Hikal S&P BSE Healthcare S&P BSE Small Cap
YTD4.2417.93-15.54
1 month6.193.294.22
3 months-3.0513.75-15.99
1 Year-30.1917.97-22.54
3 Years-4.824.50-8.90
5 Years7.85-0.111.33
10 Years9.0711.122.98
As on 03-Jun-2020
Year Hikal S&P BSE Small Cap S&P BSE Healthcare
2019-26.92-6.85-3.55
20180.05-23.41-5.89
20179.4459.640.49
201627.161.77-12.88
201510.096.7615.06
201464.7669.2447.43
2013-9.27-11.2322.55